Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responses.
Nixon AB, Navarro FCP, Zhou KI, Abbott C, McDaniel L, Howard L, Brady JC, Liu Y, Jia J, Niedzwiecki D, Strickler J, Boyle SM, Chen RO, Uronis H. Nixon AB, et al. Among authors: chen ro. Res Sq [Preprint]. 2024 Dec 18:rs.3.rs-5349536. doi: 10.21203/rs.3.rs-5349536/v1. Res Sq. 2024. PMID: 39764133 Free PMC article. Preprint.
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.
Black JRM, Bartha G, Abbott CW, Boyle SM, Karasaki T, Li B, Chen R, Harris J, Veeriah S, Colopi M, Bakir MA, Liu WK, Lyle J, Navarro FCP, Northcott J, Pyke RM, Hill MS, Thol K, Huebner A, Bailey C, Colliver EC, Martínez-Ruiz C, Grigoriadis K, Pawlik P, Moore DA, Marinelli D, Shutkever OG, Murphy C, Sivakumar M; TRACERx consortium; Shaw JA, Hackshaw A, McGranahan N, Jamal-Hanjani M, Frankell AM, Chen RO, Swanton C. Black JRM, et al. Among authors: chen ro. Nat Med. 2025 Jan;31(1):70-76. doi: 10.1038/s41591-024-03216-y. Epub 2025 Jan 13. Nat Med. 2025. PMID: 39806071 Free PMC article.
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms.
Abbott CW, Boyle SM, Pyke RM, McDaniel LD, Levy E, Navarro FCP, Mellacheruvu D, Zhang SV, Tan M, Santiago R, Rusan ZM, Milani P, Bartha G, Harris J, McClory R, Snyder MP, Jang S, Chen R. Abbott CW, et al. Clin Cancer Res. 2021 Aug 1;27(15):4265-4276. doi: 10.1158/1078-0432.CCR-20-4314. Clin Cancer Res. 2021. PMID: 34341053 Free PMC article.
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J, Bartha G, Harris J, Li C, Navarro FCP, Pyke RM, Hong M, Zhang Q, Ma S, Chen TX, Lai J, Udar N, Saldivar JS, Ayash E, Anderson J, Li J, Cui T, Le T, Chow R, Velasco RJ, Mallo C, Santiago R, Bruce RC, Goodman LJ, Chen Y, Norton D, Chen RO, Lyle JM. Northcott J, et al. Among authors: chen ro. Oncotarget. 2024 Mar 14;15:200-218. doi: 10.18632/oncotarget.28565. Oncotarget. 2024. PMID: 38484152 Free PMC article.
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.
Till JE, McDaniel L, Chang C, Long Q, Pfeiffer SM, Lyman JP, Padrón LJ, Maurer DM, Yu JX, Spencer CN, Gherardini PF, Da Silva DM, LaVallee TM, Abbott C, Chen RO, Boyle SM, Bhagwat N, Cannas S, Sagreiya H, Li W, Yee SS, Abdalla A, Wang Z, Yin M, Ballinger D, Wissel P, Eads J, Karasic T, Schneider C, O'Dwyer P, Teitelbaum U, Reiss KA, Rahma OE, Fisher GA, Ko AH, Wainberg ZA, Wolff RA, O'Reilly EM, O'Hara MH, Cabanski CR, Vonderheide RH, Carpenter EL. Till JE, et al. Among authors: chen ro. Nat Commun. 2024 Jul 9;15(1):5763. doi: 10.1038/s41467-024-49915-5. Nat Commun. 2024. PMID: 38982051 Free PMC article.
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J, Bartha G, Harris J, Li C, Navarro FCP, Pyke RM, Hong M, Zhang Q, Ma S, Chen TX, Lai J, Udar N, Saldivar JS, Ayash E, Anderson J, Li J, Cui T, Le T, Chow R, Velasco RJ, Mallo C, Santiago R, Bruce RC, Goodman LJ, Chen Y, Norton D, Chen RO, Lyle JM. Northcott J, et al. Among authors: chen ro. Oncotarget. 2024 Jun 20;15:407. doi: 10.18632/oncotarget.28581. Oncotarget. 2024. PMID: 38900651 Free PMC article. No abstract available.
Withdrawal of 'Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation'.
Pyke RM, Mellacheruvu D, Dea S, Abbott CW, Zhang SV, Phillips NA, Harris J, Bartha G, Desai S, McClory R, West J, Snyder MP, Chen R, Boyle SM. Pyke RM, et al. Mol Cell Proteomics. 2023 Apr;22(4):100511. doi: 10.1016/j.mcpro.2023.100511. Epub 2023 Apr 3. Mol Cell Proteomics. 2023. Corrected and republished in: Mol Cell Proteomics. 2023 Apr;22(4):100506. doi: 10.1016/j.mcpro.2023.100506 PMID: 37019059 Free PMC article. Corrected and republished. No abstract available.
Withdrawn: Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
Pyke RM, Mellacheruvu D, Dea S, Abbott CW, Zhang SV, Phillips NA, Harris J, Bartha G, Desai S, McClory R, West J, Snyder MP, Chen R, Boyle SM. Pyke RM, et al. Mol Cell Proteomics. 2021;20:100111. doi: 10.1016/j.mcpro.2021.100111. Epub 2021 Jun 12. Mol Cell Proteomics. 2021. Retraction in: Mol Cell Proteomics. 2023 Apr;22(4):100511. doi: 10.1016/j.mcpro.2023.100511 PMID: 34126241 Free PMC article. Retracted.
31 results